Neuroprotective effects of Acer palmatum thumb. leaf extract (KIOM-2015E) against ischemia/reperfusion-induced injury in the rat retina

Mol Vis. 2020 Oct 10:26:691-704. eCollection 2020.

Abstract

Purpose: The present study aimed to determine whether the administration of Acer palmatum thumb. leaf extract (KIOM-2015E) protects against the degeneration of rat retinal ganglion cells after ischemia/reperfusion (I/R) induced by midbrain cerebral artery occlusion (MCAO).

Methods: Sprague-Dawley rats were subjected to 90 min of MCAO, which produces transient ischemia in both the retina and brain due to the use of an intraluminal filament that blocks the ophthalmic and middle cerebral arteries. This was followed by reperfusion under anesthesia with isoflurane. The day after surgery, the eyes were treated three times (eye drop) or one time (oral administration) daily with KIOM-2015E for five days. Retinal histology was assessed in flat mounts and vertical sections to determine the effect of KIOM-2015E on I/R injury.

Results: A significant loss of brain-specific homeobox/POU domain protein 3A (Brn3a) and neuron-specific class III beta-tubulin (Tuj-1) fluorescence and a marked increase in glial fibrillary acidic protein (GFAP) and glutamine synthetase (GS) expression were observed after five days in the PBS-treated MCAO group compared to the sham-operated control group. However, KIOM-2015E treatment reduced (1) MCAO-induced upregulation of GFAP and GS, (2) retinal ganglion cell loss, (3) nerve fiber degeneration, and (4) the number of TUNEL-positive cells. KIOM-2015E application also increased staining for parvalbumin (a marker of horizontal cell associated calcium-binding protein and amacrine cells) and recoverin (a marker of photoreceptor expression) in rats subjected to MCAO-induced retinal damage.

Conclusions: Our findings indicated that KIOM-2015E treatment exerted protective effects against retinal damage following MCAO injury and that this extract may aid in the development of novel therapeutic strategies for retinal diseases, such as glaucoma and age-related macular disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acer / chemistry
  • Acer / metabolism*
  • Animals
  • Apoptosis / drug effects*
  • Chromatography, High Pressure Liquid
  • Down-Regulation
  • Glial Fibrillary Acidic Protein / metabolism
  • Glutamate-Ammonia Ligase / metabolism
  • Male
  • Nerve Fibers / pathology
  • Neuroprotective Agents / pharmacology*
  • Plant Extracts / pharmacology*
  • Plant Leaves / chemistry
  • Plant Leaves / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Reperfusion Injury / complications
  • Reperfusion Injury / metabolism*
  • Reperfusion Injury / mortality
  • Retinal Degeneration / complications
  • Retinal Degeneration / metabolism
  • Retinal Degeneration / prevention & control*
  • Retinal Ganglion Cells / cytology
  • Retinal Ganglion Cells / drug effects*
  • Retinal Ganglion Cells / pathology
  • Transcription Factor Brn-3B / metabolism
  • Tubulin / metabolism
  • Up-Regulation

Substances

  • GFAP protein, rat
  • Glial Fibrillary Acidic Protein
  • Neuroprotective Agents
  • Plant Extracts
  • Pou4f2 protein, rat
  • Transcription Factor Brn-3B
  • Tubb3 protein, rat
  • Tubulin
  • Glutamate-Ammonia Ligase